NASDAQ:SGRY - Surgery Partners Stock Price, News & Analysis

$6.36
+0.10 (+1.60 %)
(As of 08/23/2019 10:26 AM ET)
Today's Range
$6.14
Now: $6.36
$6.36
50-Day Range
$5.68
MA: $7.05
$8.23
52-Week Range
$5.38
Now: $6.36
$18.50
Volume30,519 shs
Average Volume441,887 shs
Market Capitalization$314.69 million
P/E RatioN/A
Dividend YieldN/A
Beta2.27
Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. Read More…

Industry, Sector and Symbol

Industry General medical & surgical hospitals
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SGRY
CUSIPN/A
Phone615-234-5900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.77 billion
Book Value$21.12 per share

Profitability

Net Income$-205,710,000.00

Miscellaneous

Employees11,000
Market Cap$314.69 million
Next Earnings Date11/6/2019 (Estimated)
OptionableOptionable

Receive SGRY News and Ratings via Email

Sign-up to receive the latest news and ratings for SGRY and its competitors with MarketBeat's FREE daily newsletter.


Surgery Partners (NASDAQ:SGRY) Frequently Asked Questions

What is Surgery Partners' stock symbol?

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

How will Surgery Partners' stock buyback program work?

Surgery Partners declared that its Board of Directors has initiated a share repurchase plan on Saturday, December 16th 2017, which allows the company to repurchase $50,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to purchase shares of its stock through open market purchases. Shares repurchase plans are usually an indication that the company's board believes its shares are undervalued.

How were Surgery Partners' earnings last quarter?

Surgery Partners Inc (NASDAQ:SGRY) posted its quarterly earnings results on Wednesday, August, 7th. The company reported ($0.35) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.22) by $0.13. The firm had revenue of $445.40 million for the quarter, compared to the consensus estimate of $450.89 million. Surgery Partners had a negative net margin of 11.61% and a negative return on equity of 4.65%. The business's revenue for the quarter was up 2.0% on a year-over-year basis. During the same period in the prior year, the business posted ($0.57) EPS. View Surgery Partners' Earnings History.

When is Surgery Partners' next earnings date?

Surgery Partners is scheduled to release their next quarterly earnings announcement on Wednesday, November 6th 2019. View Earnings Estimates for Surgery Partners.

What price target have analysts set for SGRY?

3 brokers have issued 12-month price targets for Surgery Partners' shares. Their predictions range from $12.00 to $15.00. On average, they anticipate Surgery Partners' stock price to reach $13.50 in the next twelve months. This suggests a possible upside of 116.7% from the stock's current price. View Analyst Price Targets for Surgery Partners.

What is the consensus analysts' recommendation for Surgery Partners?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Surgery Partners.

Has Surgery Partners been receiving favorable news coverage?

News articles about SGRY stock have trended positive recently, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Surgery Partners earned a daily sentiment score of 2.5 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 6.0 out of 10, meaning that recent media coverage is somewhat likely to have an impact on the company's share price in the near term. View News Stories for Surgery Partners.

Who are some of Surgery Partners' key competitors?

What other stocks do shareholders of Surgery Partners own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Surgery Partners investors own include Mazor Robotics (MZOR), Allena Pharmaceuticals (ALNA), Rigel Pharmaceuticals (RIGL), Athersys (ATHX), Xilinx (XLNX), Liberty Oilfield Services (LBRT), SM Energy (SM), Visa (V), American Airlines Group (AAL) and Ardelyx (ARDX).

Who are Surgery Partners' key executives?

Surgery Partners' management team includes the folowing people:
  • Mr. Wayne Scott DeVeydt, CEO & Director (Age 49)
  • Mr. Thomas Francis Cowhey, Exec. VP, CFO & Principal Accounting Officer (Age 47)
  • Ms. Jennifer B. Baldock, Exec. VP & Chief Legal Officer (Age 48)
  • Dr. Angela Justice Ph.D., Exec. VP & Chief HR Officer (Age 46)
  • Mr. George M. Goodwin, Pres of American Group (Age 58)

Who are Surgery Partners' major shareholders?

Surgery Partners' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (3.55%), BlackRock Inc. (3.47%), AMI Asset Management Corp (1.89%), Pictet Asset Management Ltd. (1.32%), Pictet Asset Management Ltd. (1.32%) and Citadel Advisors LLC (1.10%). Company insiders that own Surgery Partners stock include Adam T Feinstein, Brandan Lingle, HIG Surgery Centers, Llc and Jason Eric Evans. View Institutional Ownership Trends for Surgery Partners.

Which major investors are selling Surgery Partners stock?

SGRY stock was sold by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., JPMorgan Chase & Co., Pictet Asset Management Ltd., Pictet Asset Management Ltd., Wells Fargo & Company MN, Bank of America Corp DE, Parametric Portfolio Associates LLC and Cubist Systematic Strategies LLC. Company insiders that have sold Surgery Partners company stock in the last year include Adam T Feinstein and Brandan Lingle. View Insider Buying and Selling for Surgery Partners.

Which major investors are buying Surgery Partners stock?

SGRY stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Vanguard Group Inc., AMI Asset Management Corp, Marshall Wace LLP, Citadel Advisors LLC, Dimension Capital Management LLC, Charles Schwab Investment Management Inc. and Strs Ohio. View Insider Buying and Selling for Surgery Partners.

How do I buy shares of Surgery Partners?

Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Surgery Partners' stock price today?

One share of SGRY stock can currently be purchased for approximately $6.23.

How big of a company is Surgery Partners?

Surgery Partners has a market capitalization of $308.26 million and generates $1.77 billion in revenue each year. The company earns $-205,710,000.00 in net income (profit) each year or ($2.45) on an earnings per share basis. Surgery Partners employs 11,000 workers across the globe.View Additional Information About Surgery Partners.

What is Surgery Partners' official website?

The official website for Surgery Partners is http://www.surgerypartners.com/.

How can I contact Surgery Partners?

Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at 615-234-5900 or via email at [email protected]


MarketBeat Community Rating for Surgery Partners (NASDAQ SGRY)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  202 (Vote Outperform)
Underperform Votes:  266 (Vote Underperform)
Total Votes:  468
MarketBeat's community ratings are surveys of what our community members think about Surgery Partners and other stocks. Vote "Outperform" if you believe SGRY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SGRY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/23/2019 by MarketBeat.com Staff

Featured Article: Call Option Volume

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel